Jim Tananbaum improves lives by harnessing healthcare’s future.

Jim Tananbaum is the CEO of Foresite Capital, a company he founded in 2011 as a private equity firm dedicated to identifying and nurturing emerging healthcare leaders. He has experience in the healthcare industry spanning for over 25 years as an investment strategist and healthcare entrepreneur. According to Mr. Tananbaum, Foresite Capital harnesses the future of healthcare. You can visit Ideamensch for more info.

Before founding Foresite, Jim Tananbaum had co-founded two leading biopharmaceutical companies; GelTex and Theravance, Inc. GelTex Pharmaceuticals brought to the market two new drugs at a cost less than $80 million. It was acquired later acquired at $1.6 billion. Today the market capitalization of the two companies is about $3.2 billion.

Jim Tananbaum has been on Forbes magazine’s Midas List for three consecutive years. The consistency is mainly due to his high investment in the healthcare industry. His early investment experience was a partner at Sierra Ventures then later as a founding partner of Prospect Venture II and III. The major investments which Mr. Tananbaum has led include Amira Pharmaceuticals, Healtheon, Jazz Pharmaceuticals and Amerigroup among others.

Jim Tananbaum founded Foresite Capital with the aim of creating a platform that brings together all the disciplines of his career. Intarcia is currently the company’s largest investment. It is a type II diabetes implant that controlling diabetes and weight gain. Jim believes that Intarcia has the potential to immensely control diabetes. If launched, it will improve the lives of millions of people since over 350 million people are either diabetic or obese globally.

Also, Foresite has invested in Aeri Pharmaceuticals to develop glaucoma treatment. Glaucoma is a principal cause of blindness and affects over 40 million people globally. It has also sponsored numerous other healthcare investments in synthetic biology, gene sequencing, data science and healthcare delivery.

Jim Tananbaum obtained a bachelor’s of science degree in mathematics and electrical engineering from Yale University before graduating with a master’s of science from MIT in 1989. He also holds a Doctor of Medicine (M.D) and MBA from Harvard Medical School and Harvard Business school respectively. His strategy is to focus on the next trend in healthcare and develop expertise for it. Checkout Forbes to know more.

Check out the website officialjimtananbaum.com

Source: http://www.fiercebiotech.com/venture-capital/foresite-capital-reloads-a-450m-biotech-venture-fund